期刊文献+

CO_(2)点阵激光、他克莫司联合复方甘草酸苷片治疗稳定期非节段型白癜风的效果观察 被引量:1

Effect of CO_(2) dot matrix laser combined with tacrolimus and compound glycyrrhizin tablets on stable non segmental vitiligo
原文传递
导出
摘要 目的探讨CO_(2)点阵激光、他克莫司联合复方甘草酸苷片治疗稳定期非节段型白癜风的临床效果。方法抽取驻马店市第一人民医院2020年3月至2021年3月收治的90例稳定期非节段型白癜风患者,依据随机数字表法分为对照组(45例)和观察组(45例)。对照组给予CO_(2)点阵式激光照射及他克莫司乳膏涂抹治疗,观察组在对照组治疗基础上联合应用复方甘草酸苷片口服。比较两组患者治疗后3、6个月的临床效果,同时记录治疗期间两组不良反应发生情况。结果治疗3个月后,观察组总有效率(55.56%,25/45)与对照组(35.56%,16/45)比较,差异未见统计学意义(P>0.05);治疗6个月后,观察组总有效率(80.00%,36/45)高于对照组(42.22%,19/45),P<0.05。两组不良反应发生率比较,差异未见统计学意义(P>0.05)。结论CO_(2)点阵激光、他克莫司联合复方甘草酸苷片治疗稳定型非节段性白癜风的疗效较好,安全性较高。 Objective To investigate the clinical effects of CO_(2) dot matrix laser combined with tacrolimus and compound glycyrrhizin tablets in the treatment of stable non segmental vitiligo.Methods Ninety patients with stable non segmental vitiligo treated in Zhumadian First People’s Hospital from March 2020 to March 2021 were selected and divided into control group(45 cases)and observation group(45 cases)by random number table method.The control group was treated by CO_(2) dot matrix laser irradiation and tacrolimus cream,and the observation group was treated with compound glycyrrhizin tablets based on the treatment of the control group.The 3-and 6-month postoperative clinical effects of the two groups were compared,and the adverse reactions during the treatment were recorded.Results After 3 months of treatment,there was no significant difference in the total effective rate between the observation group(55.56%,25/45)and the control group(35.56%,16/45),P>0.05.After 6 months of treatment,the total effective rate of the observation group(80.00%,36/45)was higher than that of the control group(42.22%,19/45),P<0.05.There was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusions CO_(2) dot matrix laser combined with tacrolimus and compound glycyrrhizin tablets is effective and safe in the treatment of stable non segmental vitiligo.
作者 魏靖 刘黎明 吴水芹 Wei Jing;Liu Liming;Wu Shuiqin(Department of Dermatology,Zhumadian First People’s Hospital,Zhumadian 463000,China)
出处 《中国实用医刊》 2022年第7期74-76,共3页 Chinese Journal of Practical Medicine
关键词 白癜风 CO_(2)点阵激光 他克莫司 复方甘草酸苷片 Vitiligo CO_(2)lattice laser Tacrolimus Compound glycyrrhizin tablets
  • 相关文献

参考文献9

二级参考文献54

  • 1白癜风临床分型及疗效标准(2003年修订稿)[J].中华皮肤科杂志,2004,37(7):440-440. 被引量:801
  • 2中国中西医结合学会皮肤性病专业委员会色素病学组.黄褐斑和白癜风的诊疗标准(2010年版)[J].中华皮肤科杂志,2010,43(06):373.
  • 3Ezzedine K, Lim HW, Suzuki T, et al. Revised classification/nomen-clature of vitiligo and related issues : the Vitiligo Global Issues Con-sensus Conference[ J]. Pigment Cell Melanoma Res,2012 ,25 ( 3 ) : El-E13.
  • 4Zhou L,Li K, Shi YL,et al. Systemic analyses of immunophenotypesof peripheral T cells in non-segmental vitiligo : implication of defectivenatural killer T cells[ J]. Pigment Cell Melanoma Res,2012,25 (5 ):602 -611.
  • 5Yang Z, Klionsky DJ. Eaten alive: a history of macroautophagy [ J].Nat Cell Biol,2010,12(9) :814 -822.
  • 6Deretic V. Autophagy in immunity and cell-autonomous defense againstintracellular microbes [ J ] . Immunol Rev ,2011,240 (1) : 92 - 104.
  • 7Jeong TJ, Shin MK, Uhm YK, et al. Association of UVRAG polymor-phisms with susceptibility to non-segmental vitiligo in a Korean sample[J]. Exp Dermatol ,2010,19(8) :e323 - e325.
  • 8Jin Y,Mailloux CM, Gowan K, et al. NALP1 in vitiligo-associatedmultiple autoimmune disease[J]. N Engl J Med,2007 ,356(12) : 1216-1225.
  • 9Jin Y, Birlea SA, Fain PR, et al. Variant of TYR and autoimmunitysusceptibility loci in generalized vitiligo[ J]. N Engl J Med,2010,362.18) :1686 -1697.
  • 10Wang CQ, Cruz-Inigo AE, Fuentes-Duculan J, et al. Thl7 cells andactivated dendritic cells are increased in vitiligo lesions[ J]. PLoS One,2011,6(4) :el8907.

共引文献51

同被引文献13

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部